The Journal of Organic Chemistry
Article
(
silica-gel, EtOAc/hexanes 2:8) to obtain compound 9 (∼25% yield,
dioxaborolane (HBpin, ∼153.6 mg, 1.2 mmol, 1.2 equiv), purified by
flash column chromatography eluting with hexanes/DCM (1:1) to
1
containing a minor amount of impurities). H NMR (400 MHz;
CDCl ): δ 7.31−7.15 (m, 2H), 6.88−6.74 (m, 2H), 6.72 (m, 2H), 6.37
provide the title compound as a colorless oil (193 mg, 0.70 mmol, 67%
3
1
(
m, 1H), 6.21 (m, 1H), 5.19 (dt, J = 3.5, 1.7 Hz, 1H), 3.81 (tdd, J = 6.6,
yield). H NMR (300 MHz, CDCl ): δ 7.38−6.97 (m, 2H), 7.10−6.56
3
2
.8, 1.5 Hz, 2H), 3.73−3.64 (m, 1H), 3.50 (s, 3H), and 2.98 (s, 6H)
(m, 2H), 3.85 (s, 3H), 3.22−2.40 (m, 2H), 1.27 (d, 12H), and 1.24−
13
1
13
1
ppm; C{ H} NMR (101 MHz; CDCl ): δ 149.8, 147.6, 140.0, 139.2,
1.10 (m, 2H); C{ H} NMR (76 MHz, CDCl ): δ 157.4, 132.8, 129.1,
3
3
11
1
1
29.0, 128.5, 126.5, 119.8, 112.3, 74.6, 56.6, 41.4, 40.6, and 39.6 ppm;
126.7, 120.3, 110.1, 83.0, 55.2, 24.9, and 24.4 ppm; B{ H} NMR (96
−
1
IR (Neat) 2886, 2809, 1603, 1520, and 1443 cm ; HRMS (ESI+) m/
z: [M + H] calcd for C H NO, 268.1696; found, 268.1697.
MHz, CDCl ): δ 34.09 ppm. The NMR is consistent with literature
3
+
44
data.
1
8
22
Characterization Data of Products in Scheme 5. 4,4,5,5-
Tetramethyl-2-phenethyl-1,3,2-dioxaborolane (14a). Prepared ac-
cording to the general procedure from styrene (1.0 mmol) and 4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (HBpin, ∼153.6 mg, 1.2 mmol, 1.2
equiv), purified by flash column chromatography eluting with hexanes/
4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)phenyl
Acetate (14g). Prepared according to the general procedure from 4-
vinylphenyl acetate (1.0 mmol) and 4,4,5,5-tetramethyl-1,3,2-dioxa-
borolane (HBpin, ∼153.6 mg, 1.2 mmol, 1.2 equiv), purified by flash
column chromatography eluting with hexanes/DCM (1:1) to provide
DCM (1:1) to provide the title compound as a colorless oil (197 mg,
the title compound as a colorless oil (104 mg, 0.36 mmol, 36% yield).
1
1
0
4
1
1
.85 mmol, 85% yield). H NMR (400 MHz, CDCl ): δ 7.37−7.27 (m,
H NMR (400 MHz, CDCl ): δ 7.23 (d, J = 8.4 Hz, 2H), 6.99 (d, J = 8.4
3
3
H), 7.25−7.18 (m, 1H), 2.88−2.80 (m, 2H), 1.29 (s, 12H), and 1.26−
Hz, 2H), 2.76 (t, J = 8.2 Hz, 2H), 2.30 (s, 3H), 1.24 (s, 12H), and 1.19−
.20 (m, 2H) ppm; 13C{ H} NMR (101 MHz, CDCl ): δ 144.5, 128.2,
1
13
1
3
1.12 (m, 2H) ppm; C{ H} NMR (101 MHz, CDCl ): δ 169.7, 148.5,
3
11
1
11
1
28.1, 125.6, 83.1, 30.0, 24.9, and 13.1 ppm; B{ H} NMR (128 MHz,
142.0, 128.9, 121.1, 83.2, 29.4, 24.8, and 21.2 ppm; B{ H} NMR (128
4c
CDCl ): δ 33.92 ppm. The NMR is consistent with literature data.
MHz, CDCl ): δ 34.62 ppm. The NMR is consistent with the literature
3
3
4c
4
,4,5,5-Tetramethyl-2-(4-methylphenethyl)-1,3,2-dioxaborolane
14b). Prepared according to the general procedure from 1-methyl-4-
vinylbenzene (1.0 mmol) and 4,4,5,5-tetramethyl-1,3,2-dioxaborolane
data.
(
2-(4-Bromophenethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(14h). Prepared according to the general procedure from 1-bromo-4-
vinylbenzene (1.0 mmol) and 4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(HBpin, ∼153.6 mg, 1.2 mmol, 1.2 equiv), purified by flash column
chromatography eluting with hexanes/DCM (1:1) to provide the title
(
HBpin, ∼153.6 mg, 1.2 mmol, 1.2 equiv), purified by flash column
chromatography eluting with hexanes/DCM (1:1) to provide the title
compound as a colorless oil (192 mg, 0.78 mmol, 78% yield). H NMR
1
1
(
3
400 MHz, CDCl ): δ 7.31−6.93 (m, 4H), 2.90−2.67 (m, 2H), 2.37 (s,
compound as a white solid (233 mg, 0.75 mmol, 75% yield). H NMR
3
13
1
H), 1.29 (s, 12H), and 1.19 (dd, J = 9.0, 7.5 Hz, 2H) ppm; C{ H}
(400 MHz, CDCl ): δ 7.48−7.31 (m, 2H), 7.23−6.98 (m, 2H), 2.72 (t,
3
NMR (101 MHz, CDCl ): δ 141.4, 134.9, 128.9, 127.9, 83.1, 29.6, 24.9,
J = 8.1 Hz, 2H), 1.24 (d, J = 1.8 Hz, 12H), and 1.13 (dd, J = 9.2, 7.0 Hz,
3
2
1.0, and 13.3 ppm; 11B{ H} NMR (128 MHz, CDCl ): δ 34.03 ppm.
1
2H) ppm; C{ H} NMR (101 MHz, CDCl ): δ 143.4, 131.2, 129.8,
13
1
3
3
4c
11
1
The NMR is consistent with literature data.
119.2, 83.2, 29.4, 24.8, and 12.8 ppm; B{ H} NMR (128 MHz,
43
4
,4,5,5-Tetramethyl-2-(2-phenylpropyl)-1,3,2-dioxaborolane
14c). Prepared according to the general procedure from prop-1-en-2-
ylbenzene (1.0 mmol) and 4,4,5,5-tetramethyl-1,3,2-dioxaborolane
CDCl ): δ 33.81 ppm. The NMR is consistent with literature data.
3
(
2-(2-(4-Chlorophenyl)propyl)-4,4,5,5-tetramethyl-1,3,2-dioxa-
borolane (14i). Prepared according to the general procedure from 1-
chloro-4-(prop-1-en-2-yl)benzene (1.0 mmol) and 4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (HBpin, ∼153.6 mg, 1.2 mmol, 1.2 equiv), purified
by flash column chromatography eluting with hexanes/DCM (1:1) to
(
HBpin, ∼153.6 mg, 1.2 mmol, 1.2 equiv), purified by flash column
chromatography eluting with hexanes/DCM (1:1) to provide the title
compound as a colorless oil (160 mg, 0.65 mmol, 65% yield). H NMR
1
(
400 MHz, CDCl ): δ 7.32−7.25 (m, 4H), 7.17 (ddd, J = 8.6, 5.9, 2.2
provide the title compound as a colorless oil (115 mg, 0.41 mmol, 41%
3
1
Hz, 1H), 3.19−2.96 (m, 1H), 1.31 (d, J = 6.9 Hz, 3H), and 1.21−1.17
yield). H NMR (400 MHz, CDCl ): δ 7.28−7.21 (m, 2H), 7.21−7.15
3
1
3
1
(m, 14H) ppm; C{ H} NMR (101 MHz, CDCl ): δ 149.2, 128.2,
(m, 2H), 3.03 (h, J = 7.2 Hz, 1H), 1.27 (d, J = 6.9 Hz, 3H), 1.18 (d, J =
3
26.6, 125.7, 83.0, 35.8, 24.9, and 21.2 ppm; 11B{ H} NMR (128 MHz,
1
1.8 Hz, 12H), and 1.14 (d, J = 7.8 Hz, 2H) ppm; C{ H} NMR (101
13
1
1
41
CDCl ): δ 33.59 ppm. The NMR is consistent with literature data.
MHz, CDCl ): δ 147.7, 131.2, 128.2, 128.0, 83.1, 35.3, 24.9, 24.8, 24.7,
3
3
11
1
(
R)-2-(2-(4-Methoxyphenyl)-1-phenylethyl)-4,4,5,5-tetrameth-
and 21.2 ppm; B{ H} NMR (128 MHz, CDCl ): δ 33.59 ppm. The
3
45
yl1,3,2-dioxaborolane (14d). Prepared according to the general
procedure from (E)-1,2-diphenylethene (1.0 mmol) and 4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (HBpin, ∼153.6 mg, 1.2 mmol, 1.2
equiv), purified by flash column chromatography eluting with hexanes/
NMR is consistent with literature data.
Trimethyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
propyl)silane (14j). Prepared according to the general procedure from
allyltrimethylsilane (1.0 mmol) and 4,4,5,5-tetramethyl-1,3,2-dioxabor-
olane (HBpin, ∼153.6 mg, 1.2 mmol, 1.2 equiv), purified by flash
column chromatography eluting with hexanes/DCM (1:1) to provide
DCM (1:1) to provide the title compound as a colorless oil (123 mg,
1
0
1
2
.40 mmol, 40% yield). H NMR (400 MHz, CDCl ): δ 7.44−6.98 (m,
3
0H), 3.18 (dd, J = 13.5, 9.8 Hz, 1H), 2.99 (dd, J = 13.5, 6.9 Hz, 1H),
.72 (dd, J = 9.8, 6.9 Hz, 1H), 1.37−1.20 (m, 6H), and 1.14 (d, J = 3.4
the title compound as a colorless oil (145 mg, 0.60 mmol, 60% yield).
1
H NMR (400 MHz, CDCl ): δ 1.53−1.36 (m, 2H), 1.26 (s, 12H),
3
13
1
Hz, 12H) ppm; C{ H} NMR (101 MHz, CDCl ): δ 142.6, 141.8,
0.84 (t, J = 7.7 Hz, 2H), 0.58−0.46 (m, 2H), and −0.02 (s, 9H) ppm;
3
13
1
1
28.9, 128.4, 128.3, 128.0, 125.8, 83.4, 38.9, 24.8, 24.6, and 24.5 ppm;
C{ H} NMR (101 MHz, CDCl ): δ 82.8, 24.8, 20.1, 18.6, and −1.6
3
1
1
1
11
1
B{ H} NMR (128 MHz, CDCl ): δ 33.66 ppm. The NMR is
ppm; B{ H} NMR (128 MHz, CDCl ): δ 34.03 ppm. The NMR is
consistent with literature data.
3
3
42
46
consistent with literature data.
2
-(4-Methoxyphenethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaboro-
2-(5-Bromopentyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(14k). Prepared according to the general procedure from 5-bromopent-
1-ene (1.0 mmol) and 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (HBpin,
∼153.6 mg, 1.2 mmol, 1.2 equiv), purified by flash column
chromatography eluting with hexanes/DCM (1:1) to provide the
lane (14e). Prepared according to the general procedure from 1-
methoxy-4-vinylbenzene (1.0 mmol) and 4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (HBpin, ∼153.6 mg, 1.2 mmol, 1.2 equiv), purified by
flash column chromatography eluting with hexanes/DCM (1:1) to
1
provide the title compound as a colorless oil (152 mg, 0.58 mmol, 58%
yield). H NMR (400 MHz, CDCl ): δ 7.16 (d, J = 8.5 Hz, 2H), 6.83 (d,
title compound as a colorless oil (193 mg, 0.70 mmol, 70% yield). H
1
NMR (400 MHz, CDCl ): δ 3.39 (t, J = 6.9 Hz, 2H), 2.04−1.70 (m,
3
3
J = 8.6 Hz, 2H), 3.80 (s, 3H), 3.00−2.58 (m, 2H), 1.24 (s, 12H), and
2H), 1.56−1.33 (m, 4H), 1.23 (s, 12H), and 0.77 (dt, J = 7.3, 3.8 Hz,
1
13
1
1
.14 (dd, J = 8.8, 7.5 Hz, 2H) ppm; 13C{ H} NMR (101 MHz, CDCl ):
2H) ppm; C{ H} NMR (101 MHz, CDCl ): δ 82.9, 33.9, 32.6, 30.8,
3
3
11
1
11
1
δ 157.6, 136.6, 128.9, 113.6, 83.1, 55.3, 29.1, and 24.8 ppm; B{ H}
NMR (128 MHz, CDCl ): δ 34.09 ppm. The NMR is consistent with
24.8, and 23.2 ppm; B{ H} NMR (128 MHz, CDCl ): δ 34.05 ppm.
3
46
The NMR is consistent with literature data.
3
43
literature data.
2
Characterization Data of Products in Scheme 6. 2-Phenyl-
ethan-1-ol (17a). Prepared according to the general procedure from
styrene oxide (1.0 mmol) and 4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(HBpin, ∼153.6 mg, 1.2 mmol, 1.2 equiv), purified by flash column
-(2-Methoxyphenethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lane (14f). Prepared according to the general procedure from 1-
methoxy-2-vinylbenzene (1.0 mmol) and 4,4,5,5-tetramethyl-1,3,2-
9
129
J. Org. Chem. 2021, 86, 9117−9133